| Nome |
# |
|
Appropriate lung management in patients with primary antibody deficiencies, file e3835323-7b92-15e8-e053-a505fe0a3de9
|
322
|
|
Ibrutinib-based therapy impaired neutrophils microbicidal activity in patients with chronic lymphocytic leukemia during the early phases of treatment, file e3835326-84af-15e8-e053-a505fe0a3de9
|
238
|
|
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies, file e3835316-beda-15e8-e053-a505fe0a3de9
|
183
|
|
The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data, file e3835320-dd81-15e8-e053-a505fe0a3de9
|
155
|
|
Genetic stability of Campylobacter coli in patients with primary antibody deficiencies, file e3835320-c7c9-15e8-e053-a505fe0a3de9
|
154
|
|
Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire., file e3835315-6678-15e8-e053-a505fe0a3de9
|
145
|
|
Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study, file e3835315-703c-15e8-e053-a505fe0a3de9
|
140
|
|
Clinical associations of biallelic and monoallelic TNFRSF13B variants in italian primary antibody deficiency syndromes, file e3835315-948d-15e8-e053-a505fe0a3de9
|
122
|
|
Decreased IgM, IgA, and IgG response to pneumococcal vaccine in children with transient hypogammaglobulinemia of infancy, file e3835315-bbbd-15e8-e053-a505fe0a3de9
|
113
|
|
A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation, file e3835311-d4a3-15e8-e053-a505fe0a3de9
|
111
|
|
Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency, file e3835320-90e6-15e8-e053-a505fe0a3de9
|
97
|
|
Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study, file e3835320-99a4-15e8-e053-a505fe0a3de9
|
94
|
|
On the dark side of therapies with immunoglobulin concentrates: the adverse events, file e3835315-c0c0-15e8-e053-a505fe0a3de9
|
92
|
|
Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies, file e3835314-51ab-15e8-e053-a505fe0a3de9
|
88
|
|
Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia, file e3835312-abad-15e8-e053-a505fe0a3de9
|
87
|
|
The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement, file e3835317-04ea-15e8-e053-a505fe0a3de9
|
83
|
|
Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies, file e3835320-999c-15e8-e053-a505fe0a3de9
|
77
|
|
Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group, file e3835320-c7d0-15e8-e053-a505fe0a3de9
|
77
|
|
Lack of gut secretory immunoglobulin A in memory B-cell dysfunction-associated disorders: a possible gut-spleen axis, file e3835324-bba8-15e8-e053-a505fe0a3de9
|
68
|
|
Editorial: Immunoglobulin therapy in the 21st century - The dark side of the moon, file e383531f-62e9-15e8-e053-a505fe0a3de9
|
61
|
|
The EUROclass trial: defining subgroups in common variable immunodeficiency, file e3835311-9b62-15e8-e053-a505fe0a3de9
|
59
|
|
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia, file e3835326-2d59-15e8-e053-a505fe0a3de9
|
59
|
|
Current understanding and future research priorities in malignancy associated with inborn rrrors of immunity and DNA repair disorders: the perspective of an interdisciplinary working group, file e3835320-99a1-15e8-e053-a505fe0a3de9
|
58
|
|
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality, file e3835326-446f-15e8-e053-a505fe0a3de9
|
46
|
|
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases, file e3835329-1010-15e8-e053-a505fe0a3de9
|
46
|
|
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality, file e383532b-e9cc-15e8-e053-a505fe0a3de9
|
46
|
|
Risk factors for Haemophilus influenzae and pneumococcal respiratory tract colonization in CVID, file e383531d-7800-15e8-e053-a505fe0a3de9
|
44
|
|
Double-Blind, Placebo-Controlled Randomized Trial on Low Dose Azithromycin Prophilaxis in Primary Antibody Deficiencies, file e3835327-7a53-15e8-e053-a505fe0a3de9
|
43
|
|
The usefulness of scintigraphic studies in the assessment of asymptomatic bowel disease in patients with primary antibody diseases, file e3835326-57be-15e8-e053-a505fe0a3de9
|
39
|
|
SARS-CoV-2 vaccine induced atypical immune responses in antibody defects. Everybody does their best, file e383532e-158d-15e8-e053-a505fe0a3de9
|
38
|
|
B Cell Response Induced by SARS-CoV-2 infection Is boosted by the BNT162b2 vaccine in primary antibody deficiencies, file e383532e-02c3-15e8-e053-a505fe0a3de9
|
37
|
|
Autoimmune lymphoproliferative syndrome in pregnancy: a case of favorable mother - fetal outcome in a well-controlled disease, file e3835315-e1fc-15e8-e053-a505fe0a3de9
|
34
|
|
The immune system of children: the key to understanding SARS-CoV-2 susceptibility?, file e3835326-45cd-15e8-e053-a505fe0a3de9
|
32
|
|
Anti-COVID-19 vaccination in patients with
autoimmune-autoinflammatory disorders and
primary/secondary immunodeficiencies. The position of the
task force on behalf of the italian immunological societies, file e383532c-fb7e-15e8-e053-a505fe0a3de9
|
31
|
|
null, file e3835327-24ea-15e8-e053-a505fe0a3de9
|
23
|
|
IgA antibodies and IgA deficiency in SARS-CoV-2 infection, file e383532c-5c67-15e8-e053-a505fe0a3de9
|
23
|
|
Quantification of IgM and IgA Anti-Pneumococcal Capsular Polysaccharides by a New ELISA Assay: a Valuable Diagnostic and Prognostic Tool for Common Variable Immunodeficiency, file e3835311-e6a0-15e8-e053-a505fe0a3de9
|
19
|
|
Granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID): a multicenter retrospective study of patients from italian PID referral centers, file e383532e-c991-15e8-e053-a505fe0a3de9
|
18
|
|
Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency, file e3835311-7f01-15e8-e053-a505fe0a3de9
|
16
|
|
Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic, file e3835328-e21b-15e8-e053-a505fe0a3de9
|
16
|
|
Autoimmune lymphoproliferative syndrome in pregnancy: a case of favorable mother - fetal outcome in a well-controlled disease, file e3835323-6771-15e8-e053-a505fe0a3de9
|
15
|
|
Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics, file e3835311-babf-15e8-e053-a505fe0a3de9
|
13
|
|
Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia. Results of the Italian Primary Immunodeficiency Network, file e383532e-b558-15e8-e053-a505fe0a3de9
|
13
|
|
Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients, file e3835317-c33b-15e8-e053-a505fe0a3de9
|
11
|
|
SARS-CoV-2 monoclonal antibody combination therapy in patients with COVID-19 and primary antibody deficiency, file e383532e-8795-15e8-e053-a505fe0a3de9
|
11
|
|
The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency, file e3835311-e4a0-15e8-e053-a505fe0a3de9
|
10
|
|
Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces
B cell depletion through differentiation into apoptosis-prone CD21low B cells, file e3835314-2568-15e8-e053-a505fe0a3de9
|
10
|
|
Age-dependent NK cell dysfunctions in severe COVID-19 patients, file ebe64dfd-163c-488d-9816-004350c15fe1
|
10
|
|
Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C, file e3835311-d70a-15e8-e053-a505fe0a3de9
|
9
|
|
Coronavirus disease 2019 in patients with inborn errors of immunity: an international study, file e3835329-1d54-15e8-e053-a505fe0a3de9
|
9
|
|
Case report: EBV chronic infection and lymphoproliferation in four APDS patients: the challenge of proper characterization, therapy, and follow-up, file e383532c-e75d-15e8-e053-a505fe0a3de9
|
9
|
|
European surveillance of immunoglobulin safety - Results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries, file e3835311-8a89-15e8-e053-a505fe0a3de9
|
8
|
|
Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration, file e3835311-ddc8-15e8-e053-a505fe0a3de9
|
8
|
|
Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study., file e3835314-2561-15e8-e053-a505fe0a3de9
|
8
|
|
Health-related quality of life in common variable immunodeficiency Italian patients switched to remote assistance during the COVID-19 pandemic, file e3835326-2d5e-15e8-e053-a505fe0a3de9
|
8
|
|
Granulomatous-lymphocytic interstitial lung disease: an international research prioritisation, file e383532e-4e31-15e8-e053-a505fe0a3de9
|
8
|
|
Cellular immunology and COVID-19, file e383532e-4e39-15e8-e053-a505fe0a3de9
|
8
|
|
Serum free light chains in common variable immunodeficiency disorders: role in differential diagnosis and association with clinical phenotype, file e3835326-2d5b-15e8-e053-a505fe0a3de9
|
7
|
|
IGA antibody induced by immunization with pneumococcal polysaccharides is a prognostic tool in common variable immune deficiencies, file e3835328-b45e-15e8-e053-a505fe0a3de9
|
7
|
|
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity, file e383532c-5c69-15e8-e053-a505fe0a3de9
|
7
|
|
Poking COVID-19: insights on genomic constraints among immune-related genes between Qatari and Italian populations, file e383532e-1589-15e8-e053-a505fe0a3de9
|
7
|
|
Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects, file e3835314-23cc-15e8-e053-a505fe0a3de9
|
6
|
|
Case series: convalescent plasma therapy for patients with COVID-19 and primary antibody deficiency, file e383532e-1587-15e8-e053-a505fe0a3de9
|
6
|
|
T-Cell defects associated to lack of spike-specific antibodies after bnt162b2 full immunization followed by a booster dose in patients
with common variable immune deficiencies, file e383532e-febe-15e8-e053-a505fe0a3de9
|
6
|
|
Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency, file e3835312-1e0a-15e8-e053-a505fe0a3de9
|
5
|
|
Importance of B cell co-stimulation in CD4(+) T cell differentiation: X-linked agammaglobulinaemia, a human model, file e3835314-1c6a-15e8-e053-a505fe0a3de9
|
5
|
|
Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency, file e3835315-7396-15e8-e053-a505fe0a3de9
|
5
|
|
IMMUNODEFICIENCY WITH HYPERIMMUNOGLOBULINEMIA-M IN 2 FEMALE-PATIENTS IS NOT ASSOCIATED WITH ABNORMALITIES OF CD40 OR CD40 LIGAND EXPRESSION, file e3835311-6185-15e8-e053-a505fe0a3de9
|
4
|
|
Acquired C1-inhibitor deficiency asociated with antiidiotypic antibody to monoclonal immunoglobulins, file e3835311-a50a-15e8-e053-a505fe0a3de9
|
4
|
|
Circulating CD21(low) B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells, file e3835311-affe-15e8-e053-a505fe0a3de9
|
4
|
|
IGG ANTI-IGE FROM ATOPIC-DERMATITIS INDUCES MEDIATOR RELEASE FROM BASOPHILS AND MAST-CELLS, file e3835311-b7f2-15e8-e053-a505fe0a3de9
|
4
|
|
Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment, file e383531e-5a10-15e8-e053-a505fe0a3de9
|
4
|
|
PROLIFERATIVE AND CYTOTOXIC RESPONSES TO MANNOPROTEINS OF CANDIDA-ALBICANS BY PERIPHERAL-BLOOD LYMPHOCYTES OF HIV-INFECTED SUBJECTS, file e3835311-7e93-15e8-e053-a505fe0a3de9
|
3
|
|
HCV INFECTION IN PATIENTS WITH PRIMARY DEFECTS OF IMMUNOGLOBULIN PRODUCTION, file e3835311-9d71-15e8-e053-a505fe0a3de9
|
3
|
|
Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia, file e3835311-9ee1-15e8-e053-a505fe0a3de9
|
3
|
|
ANTICANDIDAL ACTIVITY AND INTERLEUKIN-1-BETA AND INTERLEUKIN-6 PRODUCTION BY POLYMORPHONUCLEAR LEUKOCYTES ARE PRESERVED IN SUBJECTS WITH AIDS, file e3835311-bac0-15e8-e053-a505fe0a3de9
|
3
|
|
Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies., file e3835311-d379-15e8-e053-a505fe0a3de9
|
3
|
|
Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors, file e3835312-06e5-15e8-e053-a505fe0a3de9
|
3
|
|
Health related quality of life in common variable immunodeficiency, file e3835312-06e7-15e8-e053-a505fe0a3de9
|
3
|
|
Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: A case report, file e3835312-4336-15e8-e053-a505fe0a3de9
|
3
|
|
Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial., file e3835312-dc1d-15e8-e053-a505fe0a3de9
|
3
|
|
Neutralizing Antibodies to Hepatitis C Virus in Perinatally Infected Children Followed Up Prospectively, file e3835314-18ae-15e8-e053-a505fe0a3de9
|
3
|
|
Otologic evaluation of patients with primary antibody deficiency, file e3835315-ffd2-15e8-e053-a505fe0a3de9
|
3
|
|
International Consensus Document (ICON): Common Variable Immunodeficiency Disorders, file e383531d-9722-15e8-e053-a505fe0a3de9
|
3
|
|
The olfactory function in patients with common variable immunodeficiency, file e3835325-60a4-15e8-e053-a505fe0a3de9
|
3
|
|
Correction to: Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group (Journal of Clinical Immunology, (2019), 39, 1, (45-54), 10.1007/s10875-018-0577-9), file e383532c-502b-15e8-e053-a505fe0a3de9
|
3
|
|
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen, file e3835311-6176-15e8-e053-a505fe0a3de9
|
2
|
|
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively, file e3835311-689e-15e8-e053-a505fe0a3de9
|
2
|
|
A novel immunodeficiency characterized by the exclusive presence of transitional B cells unresponsive to CpG, file e3835311-b8d5-15e8-e053-a505fe0a3de9
|
2
|
|
CpG drives human transitional B cells to terminal differentiation and production of natural antibodies, file e3835311-c843-15e8-e053-a505fe0a3de9
|
2
|
|
null, file e3835315-7b6c-15e8-e053-a505fe0a3de9
|
2
|
|
Pulmonary disease in primary immunodeficiency syndromes, file e3835326-e716-15e8-e053-a505fe0a3de9
|
2
|
|
The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency, file e383532e-02c8-15e8-e053-a505fe0a3de9
|
2
|
|
COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS, file aeccac62-bfc0-489a-83a1-e83ec48ebfb8
|
1
|
|
Effectiveness of Immunoglobulin Replacement Therapy on Clinical Outcome in Patients with Primary Antibody Deficiencies: Results from a Multicenter Prospective Cohort Study, file e3835312-1a0b-15e8-e053-a505fe0a3de9
|
1
|
|
Clinical use of polyvalent immunoglobulins, file e3835312-61e0-15e8-e053-a505fe0a3de9
|
1
|
|
null, file e3835315-5e9a-15e8-e053-a505fe0a3de9
|
1
|
|
B cells from nuclear factor kB essential modulator deficient patients fail to differentiate to antibody secreting cells in response to TLR9 ligand, file e3835315-7394-15e8-e053-a505fe0a3de9
|
1
|
|
Rapid infusions of human normal immunoglobulin 50 g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia, file e3835316-f436-15e8-e053-a505fe0a3de9
|
1
|
|
Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders, file e3835322-3075-15e8-e053-a505fe0a3de9
|
1
|
| Totale |
3546 |